Report Detail

Chemical & Material Global Telmisartan API Market Growth 2022-2028

  • RnM4474579
  • |
  • 29 July, 2022
  • |
  • Global
  • |
  • 118 Pages
  • |
  • LPI(LP Information)
  • |
  • Chemical & Material

The global market for Telmisartan API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Telmisartan API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Telmisartan API players cover Rundu Pharma, Jiangxi Synergy Pharmaceutical, Apeloa Pharmaceutical, Tianyu Pharmaceutical and Zhejiang Kinglyuan Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Telmisartan API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Telmisartan API market, with both quantitative and qualitative data, to help readers understand how the Telmisartan API market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.

Market Segmentation:
The study segments the Telmisartan API market and forecasts the market size by Type (Purity ≥ 99% and Purity ≥ 99.5%,), by Application (Tablet, Capsule and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Purity ≥ 99%
Purity ≥ 99.5%

Segmentation by application
Tablet
Capsule
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Rundu Pharma
Jiangxi Synergy Pharmaceutical
Apeloa Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Weightech (Hunan) Pharmaceutical
Liu He Pharmaceutical
Verdant Life Sciences
SMILAX
Cipla
Atom Pharma
Aalidhra Pharmachem
Dr. Reddy's Laboratories
InterQuim
RL Fine Chem

Chapter Introduction
Chapter 1: Scope of Telmisartan API, Research Methodology, etc.
Chapter 2: Executive Summary, global Telmisartan API market size (sales and revenue) and CAGR, Telmisartan API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Telmisartan API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Telmisartan API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Telmisartan API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Rundu Pharma, Jiangxi Synergy Pharmaceutical, Apeloa Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical, Weightech (Hunan) Pharmaceutical, Liu He Pharmaceutical, Verdant Life Sciences and SMILAX, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Telmisartan API Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Telmisartan API by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Telmisartan API by Country/Region, 2017, 2022 & 2028
  • 2.2 Telmisartan API Segment by Type
    • 2.2.1 Purity ≥ 99%
    • 2.2.2 Purity ≥ 99.5%
  • 2.3 Telmisartan API Sales by Type
    • 2.3.1 Global Telmisartan API Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Telmisartan API Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Telmisartan API Sale Price by Type (2017-2022)
  • 2.4 Telmisartan API Segment by Application
    • 2.4.1 Tablet
    • 2.4.2 Capsule
    • 2.4.3 Other
  • 2.5 Telmisartan API Sales by Application
    • 2.5.1 Global Telmisartan API Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Telmisartan API Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Telmisartan API Sale Price by Application (2017-2022)

3 Global Telmisartan API by Company

  • 3.1 Global Telmisartan API Breakdown Data by Company
    • 3.1.1 Global Telmisartan API Annual Sales by Company (2020-2022)
    • 3.1.2 Global Telmisartan API Sales Market Share by Company (2020-2022)
  • 3.2 Global Telmisartan API Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Telmisartan API Revenue by Company (2020-2022)
    • 3.2.2 Global Telmisartan API Revenue Market Share by Company (2020-2022)
  • 3.3 Global Telmisartan API Sale Price by Company
  • 3.4 Key Manufacturers Telmisartan API Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Telmisartan API Product Location Distribution
    • 3.4.2 Players Telmisartan API Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Telmisartan API by Geographic Region

  • 4.1 World Historic Telmisartan API Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Telmisartan API Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Telmisartan API Annual Revenue by Geographic Region
  • 4.2 World Historic Telmisartan API Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Telmisartan API Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Telmisartan API Annual Revenue by Country/Region
  • 4.3 Americas Telmisartan API Sales Growth
  • 4.4 APAC Telmisartan API Sales Growth
  • 4.5 Europe Telmisartan API Sales Growth
  • 4.6 Middle East & Africa Telmisartan API Sales Growth

5 Americas

  • 5.1 Americas Telmisartan API Sales by Country
    • 5.1.1 Americas Telmisartan API Sales by Country (2017-2022)
    • 5.1.2 Americas Telmisartan API Revenue by Country (2017-2022)
  • 5.2 Americas Telmisartan API Sales by Type
  • 5.3 Americas Telmisartan API Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Telmisartan API Sales by Region
    • 6.1.1 APAC Telmisartan API Sales by Region (2017-2022)
    • 6.1.2 APAC Telmisartan API Revenue by Region (2017-2022)
  • 6.2 APAC Telmisartan API Sales by Type
  • 6.3 APAC Telmisartan API Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Telmisartan API by Country
    • 7.1.1 Europe Telmisartan API Sales by Country (2017-2022)
    • 7.1.2 Europe Telmisartan API Revenue by Country (2017-2022)
  • 7.2 Europe Telmisartan API Sales by Type
  • 7.3 Europe Telmisartan API Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Telmisartan API by Country
    • 8.1.1 Middle East & Africa Telmisartan API Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Telmisartan API Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Telmisartan API Sales by Type
  • 8.3 Middle East & Africa Telmisartan API Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Telmisartan API
  • 10.3 Manufacturing Process Analysis of Telmisartan API
  • 10.4 Industry Chain Structure of Telmisartan API

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Telmisartan API Distributors
  • 11.3 Telmisartan API Customer

12 World Forecast Review for Telmisartan API by Geographic Region

  • 12.1 Global Telmisartan API Market Size Forecast by Region
    • 12.1.1 Global Telmisartan API Forecast by Region (2023-2028)
    • 12.1.2 Global Telmisartan API Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Telmisartan API Forecast by Type
  • 12.7 Global Telmisartan API Forecast by Application

13 Key Players Analysis

  • 13.1 Rundu Pharma
    • 13.1.1 Rundu Pharma Company Information
    • 13.1.2 Rundu Pharma Telmisartan API Product Offered
    • 13.1.3 Rundu Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Rundu Pharma Main Business Overview
    • 13.1.5 Rundu Pharma Latest Developments
  • 13.2 Jiangxi Synergy Pharmaceutical
    • 13.2.1 Jiangxi Synergy Pharmaceutical Company Information
    • 13.2.2 Jiangxi Synergy Pharmaceutical Telmisartan API Product Offered
    • 13.2.3 Jiangxi Synergy Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Jiangxi Synergy Pharmaceutical Main Business Overview
    • 13.2.5 Jiangxi Synergy Pharmaceutical Latest Developments
  • 13.3 Apeloa Pharmaceutical
    • 13.3.1 Apeloa Pharmaceutical Company Information
    • 13.3.2 Apeloa Pharmaceutical Telmisartan API Product Offered
    • 13.3.3 Apeloa Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Apeloa Pharmaceutical Main Business Overview
    • 13.3.5 Apeloa Pharmaceutical Latest Developments
  • 13.4 Tianyu Pharmaceutical
    • 13.4.1 Tianyu Pharmaceutical Company Information
    • 13.4.2 Tianyu Pharmaceutical Telmisartan API Product Offered
    • 13.4.3 Tianyu Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Tianyu Pharmaceutical Main Business Overview
    • 13.4.5 Tianyu Pharmaceutical Latest Developments
  • 13.5 Zhejiang Kinglyuan Pharmaceutical
    • 13.5.1 Zhejiang Kinglyuan Pharmaceutical Company Information
    • 13.5.2 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Product Offered
    • 13.5.3 Zhejiang Kinglyuan Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Zhejiang Kinglyuan Pharmaceutical Main Business Overview
    • 13.5.5 Zhejiang Kinglyuan Pharmaceutical Latest Developments
  • 13.6 Weightech (Hunan) Pharmaceutical
    • 13.6.1 Weightech (Hunan) Pharmaceutical Company Information
    • 13.6.2 Weightech (Hunan) Pharmaceutical Telmisartan API Product Offered
    • 13.6.3 Weightech (Hunan) Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Weightech (Hunan) Pharmaceutical Main Business Overview
    • 13.6.5 Weightech (Hunan) Pharmaceutical Latest Developments
  • 13.7 Liu He Pharmaceutical
    • 13.7.1 Liu He Pharmaceutical Company Information
    • 13.7.2 Liu He Pharmaceutical Telmisartan API Product Offered
    • 13.7.3 Liu He Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Liu He Pharmaceutical Main Business Overview
    • 13.7.5 Liu He Pharmaceutical Latest Developments
  • 13.8 Verdant Life Sciences
    • 13.8.1 Verdant Life Sciences Company Information
    • 13.8.2 Verdant Life Sciences Telmisartan API Product Offered
    • 13.8.3 Verdant Life Sciences Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Verdant Life Sciences Main Business Overview
    • 13.8.5 Verdant Life Sciences Latest Developments
  • 13.9 SMILAX
    • 13.9.1 SMILAX Company Information
    • 13.9.2 SMILAX Telmisartan API Product Offered
    • 13.9.3 SMILAX Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 SMILAX Main Business Overview
    • 13.9.5 SMILAX Latest Developments
  • 13.10 Cipla
    • 13.10.1 Cipla Company Information
    • 13.10.2 Cipla Telmisartan API Product Offered
    • 13.10.3 Cipla Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Cipla Main Business Overview
    • 13.10.5 Cipla Latest Developments
  • 13.11 Atom Pharma
    • 13.11.1 Atom Pharma Company Information
    • 13.11.2 Atom Pharma Telmisartan API Product Offered
    • 13.11.3 Atom Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Atom Pharma Main Business Overview
    • 13.11.5 Atom Pharma Latest Developments
  • 13.12 Aalidhra Pharmachem
    • 13.12.1 Aalidhra Pharmachem Company Information
    • 13.12.2 Aalidhra Pharmachem Telmisartan API Product Offered
    • 13.12.3 Aalidhra Pharmachem Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Aalidhra Pharmachem Main Business Overview
    • 13.12.5 Aalidhra Pharmachem Latest Developments
  • 13.13 Dr. Reddy's Laboratories
    • 13.13.1 Dr. Reddy's Laboratories Company Information
    • 13.13.2 Dr. Reddy's Laboratories Telmisartan API Product Offered
    • 13.13.3 Dr. Reddy's Laboratories Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Dr. Reddy's Laboratories Main Business Overview
    • 13.13.5 Dr. Reddy's Laboratories Latest Developments
  • 13.14 InterQuim
    • 13.14.1 InterQuim Company Information
    • 13.14.2 InterQuim Telmisartan API Product Offered
    • 13.14.3 InterQuim Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 InterQuim Main Business Overview
    • 13.14.5 InterQuim Latest Developments
  • 13.15 RL Fine Chem
    • 13.15.1 RL Fine Chem Company Information
    • 13.15.2 RL Fine Chem Telmisartan API Product Offered
    • 13.15.3 RL Fine Chem Telmisartan API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 RL Fine Chem Main Business Overview
    • 13.15.5 RL Fine Chem Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Telmisartan API. Industry analysis & Market Report on Telmisartan API is a syndicated market report, published as Global Telmisartan API Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Telmisartan API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,034.14
6,068.28
3,601.44
7,202.88
494,100.00
988,200.00
290,201.40
580,402.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report